ZymeQuest Licenses Proprietary Enzyme Technology to Publicly Traded Life Sciences Company
1/2/2008 9:26:48 AM
More...
|
ZymeQuest Exercises Option For Worldwide Rights To Blood Platelet Modification Technology
10/19/2005 5:12:58 PM
More...
|
ZymeQuest Signs Process Development And Manufacturing Agreement With Cambrex Corporation (CBM)
10/19/2005 5:12:23 PM
More...
|
ZymeQuest To Present At UBS Global Life Sciences Conference; Presentation To Be Webcast Live At 3:30 P.M. ET Thursday, September 30
10/19/2005 5:11:33 PM
More...
|
Brigham and Women's Hospital Grants Option For Worldwide Rights To Blood Platelet Modification Technology To ZymeQuest
10/19/2005 5:11:32 PM
More...
|
Chiron Corporation (CHIR) And ZymeQuest Form Partnership For Enzyme Conversion Of Red Blood Cells
10/19/2005 5:09:35 PM
More...
|
Martin L. Olsson, M.D., Ph.D. Joins ZymeQuest As Consultant In Transfusion Science
10/19/2005 5:09:34 PM
More...
|